RZLT

Rezolute (RZLT)

Rezolute Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RZLT

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	03 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/05/25	03 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/05/22	05 : 05	GlobeNewswire Inc.	Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)	NASDAQ:RZLT	Rezolute Inc
2024/05/18	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/05/16	05 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RZLT	Rezolute Inc
2024/05/16	05 : 05	GlobeNewswire Inc.	Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
2024/04/23	21 : 00	GlobeNewswire Inc.	Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting	NASDAQ:RZLT	Rezolute Inc
2024/03/12	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/03/11	23 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/03/06	21 : 30	GlobeNewswire Inc.	Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)	NASDAQ:RZLT	Rezolute Inc
2024/02/27	22 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/02/23	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/02/22	01 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/02/14	07 : 00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06 : 05	GlobeNewswire Inc.	Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
2024/01/30	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/24	22 : 00	GlobeNewswire Inc.	Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer	NASDAQ:RZLT	Rezolute Inc
2024/01/23	22 : 00	GlobeNewswire Inc.	Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
2023/12/15	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2023/12/14	22 : 00	GlobeNewswire Inc.	Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
2023/12/13	22 : 00	GlobeNewswire Inc.	Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)	NASDAQ:RZLT	Rezolute Inc
2023/11/30	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RZLT	Rezolute Inc
2023/11/23	07 : 16	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:RZLT	Rezolute Inc
2023/11/23	06 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc